Leonardo DRS, Inc. DRS 深 滬
已收盤 01-09 16:00:00 美东时间
40.99
+2.150
+5.54%
華盛通- 最 高41.355
- 今 開39.505
- 成交量 198.38万股
- 最 低 39.505
- 昨 收 38.84
- 總市值 109.03亿
- 52周最高 49.13
- 市盈率 靜 51.51
- 換手率 0.75%
- 52周最低 27.9001
- 委 比 70.46%
- 總股本 2.66亿
- 歷史最高 49.13
- 量 比 1.30
- 振 幅 4.76%
- 歷史最低 8.75
- 每 手 1
- 風險率 5.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Leonardo DRS names Sally Wallace as COO
Leonardo DRS (NASDAQ:DRS) on Tuesday appointed Sally Wallace as EVP and COO, effective immediately. Wallace has been with the company since 2002 and will continue to report to CEO John Baylouny. Wall...
01-07 05:16
Leonardo DRS shares are trading higher after the company announced the appointment of John Baylouny as its President and Chief Executive Officer.
Leonardo DRS shares are trading higher after the company announced the appointm...
01-06 04:44
Leonardo DRS Announces First On-Orbit Test Of Its Revolutionary Multi-Channel Software-defined Radio
Leonardo DRS, Inc. (NASDAQ: DRS) announced today the successful first on-orbit test of its revolutionary multi-channel software-defined radio (SDR) with integrated advanced cryptography. This milestone marks a
2025-12-17 05:02
Leonardo DRS Signs MOI With Saudi Arabia's Defense Ministry To Explore Combat Vehicle And C6ISR Partnerships Under Vision 2030
Leonardo DRS, Inc. (NASDAQ:DRS) announced today that it has signed a Memorandum of Intent (MOI) with the Kingdom of Saudi Arabia's Ministry of Defense (MOD) to explore opportunities for MOD ground combat vehicles and
2025-12-09 05:01
Leonardo DRS Awarded Contract From Chaiseri Defense System To Offer Battle Management System, Integration Support Services To Upgrade Royal Thailand Army's Stryker Situational Awareness Capabilities
Leonardo DRS, Inc. (NASDAQ: DRS) announced today that it has signed a contract from Chaiseri Defense Systems to provide its advanced Battle Management System (BMS) and integration support services to modernize the Royal
2025-11-14 05:41
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
2025-10-31 10:25
Truist Securities Maintains Buy on Leonardo DRS, Lowers Price Target to $47
Truist Securities analyst Michael Ciarmoli maintains Leonardo DRS (NASDAQ:DRS) with a Buy and lowers the price target from $49 to $47.
2025-10-30 20:47
Leonardo DRS CEO William Lynn to retire
Leonardo DRS (DRS) on Wednesday said William Lynn will retire as Chairman and Chief Executive Officer after fourteen years of leading the company. The Board of Directors has unanimously named John Bay...
2025-10-29 19:59
Leonardo DRS Raises FY2025 Adj EPS Guidance from $1.06-$1.11 to $1.07-$1.12 vs $1.10 Est; Raises FY2025 Sales Guidance from $3.525B-$3.600B to $3.550B-$3.600B vs $3.582B Est
Leonardo DRS (NASDAQ:DRS) raises FY2025 Adj EPS guidance from $1.06-$1.11 to $1.07-$1.12 vs $1.10 analyst estimate. Raises FY2025 sales outlook from $3.525 billion-$3.600 billion to $3.550 billion-$3.600 billion vs
2025-10-29 19:31
Leonardo DRS Q3 Adj. EPS $0.29 Beats $0.28 Estimate, Sales $960.000M Beat $924.797M Estimate
Leonardo DRS (NASDAQ:DRS) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.28 by 3.94 percent. This is a 20.83 percent increase over earnings of $0.24 per share from the same
2025-10-29 19:30
